Showing results (131-140 of 439) with videos related to

Sort By:
Pageof 44
Metabolism Open|June 18, 2025
Assessment of DNA glycation in the prediabetic State: Early indicator of glycemic stressTanish Baweja, Abhishek Dikshit, Shazia Bano, et al.
Metabolism Open|October 3, 2025
Corrigendum to "Effectiveness of continuous glucose monitoring systems on glycemic control in adults with type 1 diabetes: A systematic review and meta-analysis" [Metabol. Open 27 (2025) 100382]Salya F Alfadli, Yazeed S Alotaibi, Maha J Aqdi, et al.
Metabolism Open|September 25, 2025
Effect of dapagliflozin on eGFR slope in IgA nephropathy based on renal pathological assessment using image analysis softwareAkira Mima, Takahiro Nakamoto, Keishi Matsumoto, et al.
Metabolism Open|September 25, 2025
A nonlinear, causal link between serum 25-hydroxyvitamin D and prolactin in type 2 diabetes: Evidence from clinical and Mendelian randomization analysesJing He, Ying-Chuan Yin, Wang Zhang, et al.
Metabolism Open|June 30, 2025
Association of hepatic steatosis with increased plasma xanthine oxidoreductase activity: MedCity21 health examination registryMasafumi Kurajoh, Shinya Fukumoto, Seigo Akari, et al.
Metabolism Open|December 16, 2025
Gestational diabetes alters prefrontal neurochemistry and disrupts maternal behaviors: Role of Fibrillin-1, serotonin, and TNF-α in ratsSamira Khayat, Hamed Fanaei, Abdolvahed Safarzaei
Metabolism Open|April 28, 2025
Truncated variant rs373056577 confers increased risk of type 2 diabetes and missense variant rs121912717 is associated with hypertriglyceridemia in Bangladeshi populationShomoita Sayed, Abdullah Al Saba, Imrul Hasan, et al.
Metabolism Open|May 7, 2025
The potential role of adipokines and hepatokines in age-related ocular diseasesStavroula Almpanidou, Ilias D Vachliotis, Antonis Goulas, et al.
Metabolism Open|November 19, 2025
Synthetic target trial emulation and predictive modeling of amylin-pathway therapies for obesity and type 2 diabetesFaisal A Al-Harbi, Ahmed K Alsaif, Atheer G Almutairi, et al.
Metabolism Open|October 29, 2025
Elevated fasting glucose is common in lung cancer patients undergoing 18F-FDG PET/CT: A brief reportBojan Bojanic, Moritz Schwyzer, Thomas Sartoretti, et al.
Pageof 44